(Q33545720)

27 July 2017

1 reference

title

Population screening for hemochromatosis (English)

1 reference

27 July 2017

P C Adams

1

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

27 July 2017

1 reference

27 July 2017

volume

29

1 reference

27 July 2017

issue

4

1 reference

27 July 2017

page(s)

1324-1327

1 reference

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Global prevalence of putative haemochromatosis mutations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Hemochromatosis in Ireland and HFE

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Celtic origin of the C282Y mutation of hemochromatosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Long-term survival in patients with hereditary hemochromatosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Long-term survival analysis in hereditary hemochromatosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Hereditary hemochromatosis: gene discovery and its implications for population-based screening

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Management of Hemochromatosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Haemochromatosis and HLA-H.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Hemosiderosis in cirrhosis: a study of 447 native livers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Hepatic stellate cells (Ito cells) but not collagen IV may partly be responsible for lower portal pressure after reversing secondary biliary cirrhosis in the rat

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Molecular medicine and hemochromatosis: at the crossroads

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Prevalence of hereditary hemochromatosis in 16031 primary care patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Clinical and family studies in genetic hemochromatosis: microsatellite and HFE studies in five atypical families

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of Multiple-Cause Mortality Data

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Eligibility and exclusion of hemochromatosis patients as voluntary blood donors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Prevalence of Hemochromatosis among 11,065 Presumably Healthy Blood Donors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Serum ferritin, blood donation, iron stores and haemochromatosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Prevalence of hemochromatosis among first-time and repeat blood donors in Norway

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Public health surveillance for hereditary hemochromatosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Strategies to increase detection of hemochromatosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Iron overload, public health, and genetics: evaluating the evidence for hemochromatosis screening

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

The significance of haemochromatosis gene mutations in the general population: implications for screening

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Hereditary haemochromatosis mutation frequencies in the general population

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Screening for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290425

7 January 2021

Identifiers

DOI

10.1002/HEP.510290425

1 reference

27 July 2017

1 reference